CIK 0000842023
- Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- Operating
- EIN
- 411427402
- Phone
- +1 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- 4 Open-market sale Director sold 6,000 shares at $385.08 ($2,310,481)
- 4 Open-market sale Pres. Diagnostics & Genom sold 823 shares at $388.45 ($319,694)
- 4 Open-market sale President-Protein Sciences sold 32,933 shares at an average $380.68 ($12,537,023)
- 4 Open-market sale Chief Executive Officer sold 20,000 shares at $344.00 ($6,880,000)
- 4 Open-market sale Chief Financial Officer sold 10,000 shares at an average $333.63 ($3,336,322)
- 4 Open-market sale Chief Executive Officer sold 5,000 shares at $308.00 ($1,540,000)
- 4 Open-market sale SVP - General Counsel sold 10,857 shares at an average $301.94 ($3,278,126)
- 4 Open-market sale Director sold 5,000 shares at $303.34 ($1,516,675)
- 4 Open-market sale Director sold 5,023 shares at an average $306.62 ($1,540,167)
- 4/A Derivatives Options or other derivatives
- 4 Open-market sale Chief Financial Officer sold 10,991 shares at an average $307.95 ($3,384,680)
- 4/A Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Executive Officer gave up 15,375 shares (to pay taxes)
- 4 Open-market sale Director sold 10,000 shares at an average $301.99 ($3,019,948)
- 4 Open-market sale Director sold 5,000 shares at an average $300.35 ($1,501,744)
- 4 Open-market sale Chief Financial Officer sold 15,909 shares at an average $280.71 ($4,465,883)
- 4 Grant or award Director acquired 391 shares (grant or award)
- 4 Grant or award Director acquired 391 shares (grant or award)
- 4 Grant or award Director acquired 391 shares (grant or award)
- 4 Grant or award Director acquired 391 shares (grant or award)
Page 12 of 35 · 695 filings